ImmunoBiology Names Avlar Chief Alan Goodman Chairman Published: Feb 26, 2004 ImmunoBiology, a biotechnology company focused on the treatment of infectious diseases and cancer, said that it has named Alan Goodman as chairman. Related links Venturewire [Registration May Be Required] This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news